Primary Results Of Nrg Oncology/Nsabp B-43: Phase Iii Trial Comparing Concurrent Trastuzumab (T) And Radiation Therapy (Rt) With Rt Alone For Women With Her2-Positive Ductal Carcinoma In Situ (Dcis) After Lumpectomy.

Melody A. Cobleigh,Stewart J. Anderson,Kalliopi P. Siziopikou,Douglas W Arthur,Thomas B. Julian,Rachel Rabinovitch,David S. Parda,Samantha A. Seaward,Dennis L. Carter,Janice A. Lyons,Melissa S. Dillmon, Gustav Magrinat,Vivek S Kavadi,Allison M. Zibelli,Lavanya Tiriveedhi,Matthew L. Hill,Marianne Melnik,Sushil Beriwal,Eleftherios P. Mamounas,Norman Wolmark

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 10|浏览68

暂无评分

摘要

508Background: Preclinical studies report that T can boost RT effectiveness. The primary aim of this trial assessed the efficacy of concurrent T + RT vs RT alone in preventing recurrence of ipsilat...

查看译文

关键词

nrg oncology,lumpectomy,concurrent trastuzumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要